Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy

Psychiatry Research - Neuroimaging

Volumn 98, Issue 3, 2000, Pages 155-162

  Omori, Masao ^a   Murata, Tetsuhito ^a   Kimura, Hirohiko ^a   Koshimoto, Yoshio ^a   Kado, Hirotsugu ^a   Ishimori, Yoshiyuki ^a   Ito, Harumi ^a   Wada, Yuji ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Brain imaging; Brain metabolism; Choline containing compounds; Frontal lobe; N acetylaspartate

Indexed keywords

BIPERIDEN; CHOLINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CREATINE; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; THALAMUS;

ADULT; ASPARTIC ACID; CASE-CONTROL STUDIES; CHOLINE; CREATINE; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; SCHIZOPHRENIA; THALAMUS;

EID: 0034657825     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(00)00049-4     Document Type: Article

References (31)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Press, Washington, DC.
2. Andreasen N.C., Ehrhardt J.C., Swayze II V.W., Alliger R.J., Yuh W.T., Cohen G., Ziebell S. Magnetic resonance imaging of the brains in schizophrenia: the pathophysiologic significance of structural abnormalities. Archives of General Psychiatry. 47:1990;35-44.
3. Andreasen N.C., Arndt S., Swayze II V., Cizadlo T., Flaum M., O'Leary D., Ehrhardt J.C., Yuh W.T.C. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 266:1994;294-298.
4. Bartha R., Al-Semaan Y.M., Williamson P.C., Drost D.J., Malla A.K., Carr T.J., Densmore M., Canaran G., Neufeld R.W.J. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biological Psychiatry. 45:1999;1403-1411.
5. Baumer H. Veranderungen des Thalamus bei Schizophrenie. Journal fuer Hirnforschung. 1:1954;157-172.
6. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T.W., Frank J.A., Tedeschi G., Weinberger D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. American Journal of Psychiatry. 153:1996;1554-1563.
7. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., Breier A., Weinberger D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry. 43:1998;641-648.
8. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophrenia Bulletin. 19:1993;431-445.
9. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophrenia Bulletin. 19:1993;233-259.
10. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., Haier R.J., Wu J., Bunney W.E. PET and MRI of the thalamus in never-medicated patients with schizophrenia. American Journal of Psychiatry. 153:1996;191-199.
11. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biological Psychiatry. 36:1994;792-800.
12. Corey-Bloom J., Jernigan T., Archibald S., Harris M.J., Jeste D.V. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. American Journal of Psychiatry. 152:1995;447-449.
13. Crespo-Facorro B., Paradiso S., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Recalling word lists reveals 'cognitive dysmetria' in schizophrenia: a positron emission tomography study. American Journal of Psychiatry. 156:1999;386-392.
14. Flaum M., Swayze II V.W., O'Leary D.S., Yuh W.T.C., Ehrhardt J.C., Arndt S.V., Andreasen N.C. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. American Journal of Psychiatry. 152:1995;704-714.
15. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo, relaxation times and concentrations of cerebral metabolites. Magnetic Resonance in Medicine. 11:1989;47-63.
16. Fujimoto T., Nakano T., Takano T., Takeuchi K., Yamada K., Fukuzako T., Akimoto H. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Biological Psychiatry. 40:1996;14-18.
17. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., Obo Y., Ueyama K., Takigawa M., Fujimoto T. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Research: Neuroimaging. 61:1995;193-200.
18. Hazlett E.A., Buchsbaum M.S., Byne W., Wei T., Spiegel-Cohen J., Geneve C., Kinderlehrer R., Haznedar M.M., Shihabuddin L., Siever L.J. Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. American Journal of Psychiatry. 156:1999;1190-1199.
19. Heimberg C., Komoroski R.A., Lawson W.B., Cardwell D., Karson C.N. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Research: Neuroimaging. 83:1998;105-115.
20. Hempel K.J., Treff W.M. Quantitative untersuchungen uber relative zell-und Zellkernvolumina bei klinisch gesunden and schizophrenia. Journal fuer Hirnforschung. 4:1959;412-454.
21. Kay S.R. Positive and Negative Syndromes in Schizophrenia. 1991;Brunner/Mazel, New York.
22. Kreis R., Ernst T., Ross B.D. Absolute quantitation of water and metabolites in the human brain II. Metabolite concentrations. Journal of Magnetic Resonance. B102:1993;9-19.
23. Lopez-Villegas D., Kimura H., Tunlayadechanont S., Lenkinski R.E. High spatial resolution MRI and proton MRS of human frontal cortex. NMR in Biomedicine. 9:1996;297-304.
24. Menon D.K., Sargentoni J., Peden C.J., Bell J.D., Cox I.J., Coutts G.A., Baudouin C., Newman C.G. Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. Journal of Computer Assisted Tomography. 14:1990;449-452.
25. Michaelis T., Merboldt K.D., Bruhn H., Hanicke W., Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 187:1993;219-227.
26. Nadler J.V., Cooper J.R. N-acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nervous tissues. Journal of Neurochemistry. 19:1972;313-319.
27. Najim I.M., Wang Y., Shedid D., Luders H.O., Ng T.C., Comair Y.G. MRS metabolic markers of seizures and seizure-induced neuronal damage. Epilepsia. 39:1998;244-250.
28. 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia. Biological Psychiatry. 42:1997;359-366.
29. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychological Reports. 10:1962;799-812.
30. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Archives of General Psychiatry. 47:1990;1023-1028.
31. Salibi N., Brown M.A. Clinical MR Spectroscopy. 1998;Wiley-Liss, New York.